CARDIAC TROPONIN I MONITORING IN BREAST CANCER PATIENTS RECEIVING ANTHRACYCLINEOR TRASTUZUMAB THERAPY: a pilot study The main aim of the study is to understand how and when the levels of cardiac troponin I change in breast cancer patients and to monitor how the levels change throughout breast cancer treatment. Chief Investigator: Dr Peter Henriksen Number and location of participating sites (by region/ country): UK 3 sites Funder: Edinburgh and Lothians Health Foundation Start and End Date of grant award Status: Complete Document CTNI Poster ECTU (257.18 KB / PDF) UK GDPR Privacy Statement: If you have participated in this study and would like to read how it complies with UK GDPR, please read this document. Document ECTU CNTL GDPR privacy notice (80.04 KB / PDF) Sponsor: Mrs Susan Shepherd ACCORD Chief Investigator: Dr Peter Henriksen, Edinburgh Heart Centre, Western General Hospital, Edinburgh EH4 2XU. Trial manager: Morag MacLean, ECTU morag.maclean@ed.ac.uk Research nurse: Heather McVicars, Edinburgh Cancer Centre Heather.McVicars@nhslothian.scot.nhs.uk Or Karen Bell, Beatson West of Scotland Cancer Centre Karen.Bell@ggc.scot.nhs.uk ECTU Involvement: Trial management / Database This article was published on 2024-09-24
